Hypertension – Epidemiology – Mature Markets

DRG Epidemiology's coverage of hypertension comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of hypertension for each country, as well as annualized case counts projected to the national population.

In addition to forecasting prevalent patient populations, the number of drug-treatment opportunities at specific lines of therapy are also forecast across the world.

DRG Epidemiology's hypertension forecast will answer the following questions:

  • Of all people with hypertension, how many in each country across the world have been formally diagnosed?
  • Of all people diagnosed with hypertension, how many in each country across the world are drug-treated?
  • How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of hypertension over the forecast period?

All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.

In total, DRG Epidemiology forecasts 43 hypertension patient populations, as follows:

  • total prevalent cases hypertension
  • Controlled prevalent cases
  • Controlled prevalent cases
  • Controlled prevalent cases- 1 antihypertensive
  • Controlled prevalent cases- 2 antihypertensives
  • Controlled prevalent cases- 3+ antihypertensives
  • Controlled prevalent cases of htn
  • Diagnosed prevalent cases
  • Diagnosed prevalent cases hypertension
  • Diagnosed prevalent cases of htn
  • … and many more (details available on request).

Note: coverage may vary by country.

Table of contents

  • Hypertension - Epidemiology - Mature Markets
    • Introduction
      • Key Findings
        • Prevalence of Hypertension per 100 Among People Aged 20+ in 2020 and 2040
        • Relative Sizes of the Contributing Factors to the Trend in Prevalent Cases of Hypertension over the Next 20 Years
    • Epidemiology Data
    • Methods
      • Total Prevalence of Hypertension
      • Total Prevalence of Prehypertension
      • Polypharmacy
      • Percentage Diagnosed
      • Percentage Drug-Treated
      • Percentage Controlled
    • Reference Materials
      • Literature Review
        • Studies Included in the Analysis of Hypertension
        • Studies Excluded from the Analysis of Hypertension
      • Risk/Protective Factors
        • Risk/Protective Factors for Hypertension
      • Bibliography